Cognitively-Based Compassion Training for Breast Cancer Survivors

Summary

There is a growing number of evidence of how mindfulness training enhances psychological and physical well-being and coping strategies in patients with oncological illnesses. However, there are very few studies analyzing the efficacy of Compassion-Based Interventions on breast cancer survivors.

The goal of this study is to analyze enrollment, participant satisfaction and adherence to program and differences in psychological well-being, health related quality of life, fear of illness recurrence, compassion and self-compassion variables after a Compassion-Based Intervention in a Spanish breast cancer survivor sample.

This study is a randomized clinical trial of a secularized intervention called Cognitively-Based Compassion Training (CBCT). Subjects (n = 58) were randomly assigned to CBCT (n = 28) or a treatment as usual control group (TAU) (n = 28). Participants in the CBCT intervention condition were asked to meet weekly for a two (2) hour long session during two months. Pre-post-intervention and six month follow-up measures took place to evaluate: psychological well-being (somatic, depressive, and anxious symptomatology), health related quality of life (physical, social, emotional, and functional); psychological stress, coping strategies and triggering cognitions linked to cancer recurrence fear, self-compassion, compassion and mindfulness and awareness in both intervention and wait list groups.

CBCT is a promising and potentially useful intervention to enhance physical and emotional well-being in breast cancer survivors. Nevertheless, future randomized trials are needed and a process of cultural adaptation required.

Conditions

• Compassion
• Treatment as Usual

Interventions

BEHAVIORAL

CBCT

OTHER

TAU

Sponsors & Collaborators

• University of Valencia

  lead OTHER

Principal Investigators

• Edgar Gonzalez-Hernandez · Universitat de València

• Rebeca Diego Pedro, PhD · Universitat de València

• Rocío Romero Retes, PhD · Fundación Instituto Valenciano de Oncología

• Daniel Campos Bacas, PhD · Universitat Jaume I

• Lobsang Tenzin Negi aka Satya Dev Negi, PhD · Emory University / Emory-Tibet Partnership

• Diana Burichka · Universitat de València

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

25 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2016-01-11

Primary Completion

2018-07-18

Completion

2018-07-18

Countries

• Spain

Study Locations